Customer support

xie@china-sinoway.com
EnglishEnglish
banner
Products
Home

API

Imatinib Mesylate 220127-57-1

Imatinib Mesylate 220127-57-1

In-house Standard
  • Product Details

Product Information


Product name

Imatinib Mesylate

Molecular Formula

C30H35N7O4S

Molecular Weight

589.71

CAS No.

220127-57-1

Quality Standard

In-house standard

Appearance

White or slightly yellow crystalline powder


COA of Imatinib Mesylate


TEST ITEMS

SPECIFICATION

RESULTS

Appearance

White or slightly yellow crystalline powder, 
homogeneous and with fine grain size. 
No foreign particles are observed.

Slightly yellow crystalline Powder

Solubility

Soluble in water and in acids solutions, slightly soluble 
in methanol insoluble in acetone, acetonitrile and 
dilute hydroxyl alkaline solution

Confirm

Identification

Complies

Confirm

Water

≤1.0%

0.8%

Heavy metals

≤20ppm

10ppm

Melting range

212 – 220℃

214-216℃

Residue on ignition

≤0.1%

0.08%

Particle size

90% < 100 μm

50% < 50 μm

Confirm

Bulk density

NLT 0.4g/ml

0.6g/ml

Chromatographic

purity

Individual impurities: ≤0.2%

Total impurities: ≤0.5%

0.16%

0.32%

Assay

98.5%-102.0% of Imatinib mesylate,

calculated on anhydrous basis.

99.70%

Residual solvents

Ethyl acetate: ≤5000ppm

Confirm

Acetone: ≤5000ppm

Confirm

N,N-Dimethylformamide: ≤880ppm

Confirm

Methanol: ≤3000ppm

Confirm

Dichloromethane: ≤300ppm

Confirm


We provide you with high-quality imatinib mesylate powder and imatinib mesylate price is very reasonable and competitive.


Usage


Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, 
the causal agent in chronic myelogenous leukemia.


As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of 
dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.


1. A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL)

2. Echinocandin antifungal, active against infections with Aspergillus and Candida, inhibits cell wall synthesis

3. Anticancer


*Products under the patent are only for R&D use

Send A Message

If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
Related Products

Spironolactone
Spironolactone 52-01-7
EP8, USP38,99.95% up by HPLC, total impurities < 0.05%
Mupirocin powder
Mupirocin 12650-69-0
99% up by HPLC / GMP
Ceftiofur sodium
Ceftiofur sodium 104010-37-9
In-house Specification
Thymopentin
Thymopentin 69558-55-0
99% up Medical Grade
Azilsartan
Azilsartan 147403-03-0
99% up, JP/ GMP / PMDA / DMF
Carmustine
Carmustine 154-93-8
96.0% - 102.0% 
Send A Message
Send A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.

Home

Products

about

Contact